Literature DB >> 30790743

Transcranial Doppler Ultrasonography for the Management of Severe Traumatic Brain Injury After Decompressive Craniectomy.

Tao Chang1, Lihong Li1, Yanlong Yang1, Min Li1, Yan Qu1, Li Gao2.   

Abstract

BACKGROUND: Cerebral hemodynamic transformation is a relatively common finding in patients with traumatic brain injury (TBI). Knowledge of cerebral hemodynamic disturbance may assist in predicting the management outcome. Transcranial Doppler ultrasonography (TCD) monitoring of patients with TBI can be used to reveal various pathologic hemodynamic changes. The objective of this study was to compare the clinical outcomes of postoperative routine intracranial pressure (ICP) monitoring versus ICP monitoring combined with TCD monitoring in patients with brain trauma after decompressive craniectomy.
METHODS: This was a retrospective study of 30 patients with TBI who underwent ICP combined with TCD monitoring (after 2015) compared with a historical control group of 30 patients who only underwent routine ICP monitoring (in 2013-2014). ICP, partial pressure of carbon dioxide, hemoglobin, and hematocrit values were monitored and recorded on a daily basis for 7 days after operation. Neuroimaging was also performed at admission. Neurologic outcome was assessed at 2 weeks and 6 months after operation using the Glasgow Outcome Score Extended (GOS-E). Unconditional multivariable logistic regression was conducted to analyze the factors for favorable clinical outcome.
RESULTS: Two weeks after operation, there were no differences in mortality rate between the 2 groups (P = 0.643). When considering the GOS-E score at 6 months, there were no differences in clinical prognosis between the 2 groups (P = 0.101), but the ICP combined with TCD monitoring group showed a higher frequency of patients with favorable outcome compared with the routine ICP monitoring group (P = 0.043). Unconditional multivariable logistic regression results showed that no factor was independently associated with GOS-E at 6 months.
CONCLUSIONS: TCD could be helpful for the serial monitoring of cerebral hemodynamic changes after decompressive craniectomy for TBI, which could be beneficial for neurologic outcome improvement.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebral hemodynamics; Decompressive craniectomy; Intracranial pressure; Transcranial Doppler ultrasonography; Traumatic brain injury

Mesh:

Year:  2019        PMID: 30790743     DOI: 10.1016/j.wneu.2019.02.005

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  5 in total

1.  Clinical Value of TCCD for Evaluating the Prognosis of Patients with Severe Traumatic Brain Injury After Large Decompressive Craniectomy: A Retrospective Study.

Authors:  Yuan Liang; Yunyou Duan; Changyang Xing; Jinglan Jin; Lingjuan Yan; Xi Liu; Jia Wang
Journal:  Adv Ther       Date:  2022-08-07       Impact factor: 4.070

2.  Prognostic properties of the association between the S-100B protein levels and the mean cerebral blood flow velocity in patients diagnosed with severe traumatic brain injury.

Authors:  Sebastian Dzierzęcki; Mirosław Ząbek; Artur Zaczyński; Ryszard Tomasiuk
Journal:  Biomed Rep       Date:  2022-05-19

3.  Usability of the Level of the S100B Protein, the Gosling Pulsatility Index, and the Jugular Venous Oxygen Saturation for the Prediction of Mortality and Morbidity in Patients with Severe Traumatic Brain Injury.

Authors:  Ryszard Tomasiuk; Sebastian Dzierzęcki; Artur Zaczyński; Mirosław Ząbek
Journal:  Biomed Res Int       Date:  2021-10-25       Impact factor: 3.411

4.  Wearable Intracranial Pressure Monitoring Sensor for Infants.

Authors:  Baoyue Zhang; Ziyi Huang; Huixue Song; Hyun Soo Kim; Jaewon Park
Journal:  Biosensors (Basel)       Date:  2021-06-29

5.  Cerebral Pulsatility Index and In-Hospital Mortality in Chinese Patients with Traumatic Brain Injury: A Retrospective Cohort Study.

Authors:  Tao Mei; Quan Zhou; Lie Chen; Zheyong Jia; Wei Xiao; Lixin Xu
Journal:  J Clin Med       Date:  2022-03-12       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.